TWiV reveals a novel H5N1 reassortant virus in Cambodia, circulating vaccine derived poliovirus type 2 in more countries, circulation in the blood of humans of infectious parvovirus B19 coated with active proteases, and B cell receptor dependent enhancement of dengue virus infection.
Hosts: Vincent Racaniello, Dickson Despommier, Kathy Spindler, and Brianne Barker
Click arrow to play
Download TWiV 1167 (62 MB .mp3, 103 min)
Subscribe (free): Apple Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- MicrobeTV Discord Server
- MicrobeTV Fundraiser
- Novel H5N1 in Cambodia (medRxiv) 6:28
- More cVDVP2 circulation (polioeradication.org) 11:48
- Infectious parvovirus B19 with proteases (Nat Comm) 12:16
- B cell receptor enhancement of dengue disease (PLoS Path) 42:31
- Letters read on TWiV 1167 1:00:53
- Timestamps by Jolene. Thanks!
Weekly Picks 1:28:20
Brianne – See How Many Lives Vaccines Have Saved Around the World based on Lancet study
Dickson – 2024 Wildlife Photographer of the Year
Kathy – 450 Million year old arthropods preserved in fool’s gold. Primary article Pyrite video
Vincent – ‘We need to be ready for a new world’: scientists globally react to Trump election win
Listener Picks
Jack – Coronavirus vaccine update
Intro music is by Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv
Content in this podcast should not be construed as medical advice.
The post TWiV 1167: Virus cloak and entry first appeared on This Week in Virology.
This is where things get interesting…is the mouse involved, either giving or receiving the virus? This type of research raises very important questions. I wish we as a funding society and country jumped on board to understand viruses at the basic level. This TWiV episode and the previous one looking at a RNA-DNA virus reinforces my belief that we need to invest funding in basic virology…image for just 4-5 million (40-50 labs at $100,000), a drop in the bucket for a major funding agency, we fund these smaller labs. Not so much as stable multi-year funding grants but at the very least give them at least a window to pursue those virus questions that would be “cool” and may lead to downstream applications.
Josh